ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,571 | -74.2% | 27,095 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $13,818 | -19.1% | 27,095 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $17,070 | +19.0% | 27,095 | +22.6% | 0.00% | 0.0% |
| Q4 2022 | $14,342 | -62.3% | 22,095 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $38,000 | -17.4% | 22,095 | -40.4% | 0.00% | -33.3% |
| Q2 2022 | $46,000 | +91.7% | 37,095 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $24,000 | -36.8% | 37,095 | +5.7% | 0.00% | -50.0% |
| Q4 2021 | $38,000 | +18.8% | 35,095 | +101.7% | 0.00% | 0.0% |
| Q3 2021 | $32,000 | – | 17,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |